 DURHAM, N.C., April 04, 2022 GLOBE NEWSWIRE -- Humacyte, Inc. Nasdaq: HUMA, a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced that its 2022 annual meeting of shareholders will be held virtually on Thursday, June 9, 2022, at 7:30 AM eastern time. 